Injectable Antibodies: Products, Markets, Players and Forecasts

Jul 31, 2012, 08:00 ET from Reportlinker

NEW YORK, July 31, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Injectable Antibodies: Products, Markets, Players and Forecasts

The administration of therapeutic antibodies via injection is becoming an increasingly important healthcare treatment method for a growing number diseases and indications having broad implications for patient health and well-being. The inherent instability of protein drugs has led to a number of challenges as the developers of injectable antibodies attempt to deal with packaging, handling, reconstitution and drug administration issues. These challenges are being compounded by the trend to patient self-medication, as population demographics and efforts by managed care providers to control healthcare costs drive the growth in drug self-administration, particularly for chronic conditions. This trend is introducing a new class of naïve users to parenteral drug delivery. This report analyzes twenty-six injectable/Infusible therapeutic antibody drugs and examines key packaging, dosing, regulatory, economic and competitive factors that represent opportunities, risk factors and potential barriers to commercial success.


· Provides detailed analysis of injectable antibody market segments, market dynamics and market demographics

· Analyzes products, therapeutic demand drivers and evaluates commercial drug products in more than two dozen injectable antibodies

· Analyzes technologies and market development issues for injectable antibodies

· Provides market data and forecasts to 2016

· Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations

Summary of Contents

Executive Summary

Antibody Therapeutics Market Dynamics

The Antibody Therapeutics Marketspace

Clinical Trials and Drug Approvals

The Competitive Landscape

Demographics, Managed Care and Growth

Risks and Opportunities

Formulating Antibody Drugs 

Formulation Strategies

Antibody Formulation Technologies

Antibody Packaging & Delivery

Antibody Drug Distribution Strategies

Injectable Antibodies – Indications and Therapeutic Markets


Infectious Disease




Macular Degeneration

Injectable Antibody Drug Product Assessments and Forecasts

Adalimumab (Humira)

Alefacept (Amevive)

Alemtuzumab (Campath)

Belimumab (Benlysta) 

Bevacizumab (Avastin)

Brentuximab vedotin (Adcetris)

Canakinumab (Ilaris)

Certolizumab (Cimzia)

Cetuximab (Erbitux)

Denosumab (Prolia)

Eculizumab (Soliris)

Gemtuzumab (Mylotarg)

Golimumab (Simponi)

Ibritumomab (Zevalin)

Infliximab (Remicade)

Natalizumab (Tysabri)

Ofatumumab (Arzerra)

Palivizumab (Synagis) 

Panitumumab (Vectibix)

Omalizumab (Zolair)

Ranibizumab (Lucentis)

Rituximab (Rituxin)

Tocilizumab (Actemra)

Tositumomab (Bexxar)

Trastuzumab (Herceptin)

Ustekinumab (Stelara)

Market Factors

Regulatory Issues

Patient Compliance

Healthcare Economics

Company Profiles

To order this report:

Biopharmaceutical Industry: Injectable Antibodies: Products, Markets, Players and Forecasts

More  Market Research Report

Check our  Industry Analysis and Insights

Contact Nicolas:
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker